These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27009860)

  • 1. ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation.
    Noh KW; Park J; Joo EH; Lee EK; Choi EY; Kang MS
    Oncotarget; 2016 May; 7(18):25507-15. PubMed ID: 27009860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.
    Singh G; Aras S; Zea AH; Koochekpour S; Aiyar A
    J Virol; 2009 May; 83(9):4227-35. PubMed ID: 19244333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation.
    Shire K; Kapoor P; Jiang K; Hing MN; Sivachandran N; Nguyen T; Frappier L
    J Virol; 2006 Jun; 80(11):5261-72. PubMed ID: 16699006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function.
    Duellman SJ; Thompson KL; Coon JJ; Burgess RR
    J Gen Virol; 2009 Sep; 90(Pt 9):2251-9. PubMed ID: 19439552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.
    Malik-Soni N; Frappier L
    J Virol; 2014 Feb; 88(4):2323-6. PubMed ID: 24284322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
    Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
    Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter.
    Zetterberg H; Boreström C; Nilsson T; Rymo L
    Int J Oncol; 2004 Sep; 25(3):693-6. PubMed ID: 15289871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the regulation of nuclear import of Epstein-Barr virus nuclear antigen 1 (EBNA1) by phosphorylation of the nuclear localization signal.
    Nakada R; Hirano H; Matsuura Y
    Biochem Biophys Res Commun; 2017 Feb; 484(1):113-117. PubMed ID: 28104399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance.
    Kang MS; Lee EK; Soni V; Lewis TA; Koehler AN; Srinivasan V; Kieff E
    J Virol; 2011 Mar; 85(6):2859-68. PubMed ID: 21209116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
    Murakami M; Lan K; Subramanian C; Robertson ES
    J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin.
    Coppotelli G; Mughal N; Masucci MG
    Biochem Biophys Res Commun; 2013 Feb; 431(4):706-11. PubMed ID: 23348225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3.
    Shire K; Marcon E; Greenblatt J; Frappier L
    Virology; 2021 Oct; 562():103-109. PubMed ID: 34304093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.